Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
120.50    0.00 (0.00%)
Bid:
118.00
Ask:
123.00
Spread: 5.00 (4.237%)
Market Cap: £72.50m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Director/PDMR Shareholding

8 Jun 2009 17:28

RNS Number : 5627T
Intercede Group PLC
08 June 2009
 

Intercede Group plc ("Intercede" or the "Company")

Directors' Holdings in Company

And

Notification of Interest

Further to the conversion of loan notes to ordinary shares (the "Conversion") and the resultant increase in the Company's issued share capital announced on 1 June 2009, the Company has been advised of changes to the notifiable holdings of directors and significant shareholders as set out below:

The Company was notified on 5 June 2009 by the Trustees of The Azalia Trust, being persons connected with Jacques Tredoux, a director of Intercede, pursuant to DTR 3.1 and DTR 5.1, that on 1 June 2009 The Azalia Trust indirectly acquired through controlled undertakings an aggregate of 5,740,485 ordinary shares of 1p each in the Company as a result of electing to convert the Trust's indirect interests in convertible loan notes at the conversion prices of 20p and 15p per share. Following the conversion, the Trust now has an aggregate indirect holding of 11,063,128 ordinary shares, representing 22.96% of the issued ordinary share capital of the Company.

The controlled undertakings of The Azalia Trust with disclosable holdings are:

Name of undertaking

Number of shares acquired as a result of Conversion

Existing shareholding prior to Conversion

Percentage holding following Conversion

Friskney Enterprises Limited

1,800,545

0

3.74%

Ferrybridge Enterprises Limited

1,854,907

0

3.85%

React Invest Limited*

2,085,033

1,344,683

7.12%

* React Invest Limited hold a further 402,448 shares which are not for the beneficial interest of Azalia Trust giving a total shareholding of 3,832,164 shares (7.95%).

The Company was notified on 5 June 2009 by the Trustees of The Woodcock Trust, being persons connected with Jacques Tredoux, pursuant to DTR 5.1.2 (2), that as a result of the increase in the issued share capital of the Company, The Woodcock Trust is now indirectly holding 3.04% of the Company's issued share capital, having previously held 4.31% of the same. The 1,463,216 shares in which the Trust is interested are registered in the name of Pershing Keen Nominees Limited, which is a nominee of Angus Investment Holdings Limited ("Angus"). Angus is controlled by The Woodcock Trust, of which Jacques Tredoux and his wife and children are members of the class of discretionary beneficiaries.

The holdings of the directors of the Company following the Conversion are as set out in the table below:

Director

No. of shares held

% of issued share capital

R A Parris

6,472,232

13.43%

A M Walker

1,248,077

2.59%

R Hoggarth

168,721

0.35%

J S Sikorski

106,686

0.22%

The Azalia Trust and The Woodcock Trust have an aggregate indirect holding of 12,526,344 ordinary shares in the Company (26.00%). Although Jacques Tredoux does not have any direct holdings in the ordinary shares of the Company, he and his wife and children are members of the class of discretionary beneficiaries under the Trusts.

The Company wishes to clarify other significant shareholdings as at 5 June 2009 resulting from the Conversion and increase in its issued share capital to 48,178,005 ordinary shares.

Shareholder

No. of shares held

% of issued share capital

Anjar International Limited

3,241,631

6.73%

Plastic Technologies Ltd

3,147,436

6.53%

Barclayshare Nominees Limited

1,655,661

3.42%

Cogefin (Bermuda) Limited

1,582,541

3.28%

Hargreave Hale Nominees Limited

1,568,788

3.26%

For further information please visit www.intercede.com or contact:

Andrew Walker Intercede Group plc 01455 558 111

Charles Cunningham FinnCap 020 7600 1658

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQVLFBKQBLBBD
Date   Source Headline
26th Nov 20247:00 amRNSTransaction in Own Shares
25th Nov 20247:00 amRNSTransaction in Own Shares
22nd Nov 20247:00 amRNSTransaction in Own Shares
19th Nov 20247:00 amRNSTransaction in Own Shares
18th Nov 20247:00 amRNSTransaction in Own Shares
15th Nov 20247:00 amRNSTransaction in Own Shares
14th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
11th Nov 20247:00 amRNSTransaction in Own Shares
8th Nov 20247:00 amRNSTransaction in Own Shares
4th Nov 20247:00 amRNSNotice of Results & Investor Presentation
25th Oct 20247:00 amRNSShare Buyback Programme
11th Oct 20248:38 amRNSDirector/PDMR Shareholding
8th Oct 20247:00 amRNSTrading Update
1st Oct 20247:00 amRNSNotification of Trading Update and H1 FY25 Results
30th Sep 20247:00 amRNSContract Orders and Renewals
25th Sep 202412:51 pmRNSResult of AGM
20th Sep 202411:45 amRNSDirector/PDMR Shareholding
18th Sep 20247:00 amRNSContract Orders and Renewals
2nd Sep 20247:00 amRNSContract Orders and Subscription Renewals
30th Aug 20247:00 amRNSNotice of AGM and Publication of Annual Report
4th Jul 20243:58 pmRNSIssue of Equity & Total Voting Rights
28th Jun 20243:49 pmRNSIssue of Equity & Total Voting Rights
26th Jun 20247:00 amRNSPartnership with Carahsoft Technology Corp
19th Jun 20246:25 pmRNSHolding(s) in Company
18th Jun 20249:17 amRNSHolding(s) in Company
18th Jun 20247:15 amRNSDirector/PDMR Shareholding and Issue of Equity
18th Jun 20247:00 amRNSFinal Results
5th Jun 20247:00 amRNSNotice of Results & Investor Presentation
16th May 202412:00 pmRNSCapital Markets Day - Agenda Update
14th May 20246:17 pmRNSShare Incentive Scheme
26th Apr 202410:02 amRNSShare Incentive Scheme
23rd Apr 20247:00 amRNSCapital Markets Day
8th Apr 20247:00 amRNSTrading Update
2nd Apr 20247:00 amRNSContract and Subscription Renewals
25th Mar 20243:38 pmRNSHolding(s) in Company
25th Mar 20243:35 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSNew Orders and Trading Update
21st Mar 20247:00 amRNSNew Product Announcement: Launch of MyID MFA v5
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
29th Jan 20247:00 amRNSNew Orders
18th Jan 20249:55 amRNSDirector/PDMR Shareholding
3rd Jan 20247:00 amRNSMajor New Contract Win
7th Dec 20237:00 amRNSUpdate on Major New Contract Win
5th Dec 202312:30 pmRNSMajor New Contract with Large US Federal Agency
22nd Nov 20237:00 amRNSDirector/PDMR Shareholding
21st Nov 20237:01 amRNSNew Contract and Renewal Orders
21st Nov 20237:00 amRNSHalf-year Report
7th Nov 20237:00 amRNSContract and Renewals Orders

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.